AI Portfolio Summary
In 2025 Q4, Atle Fund Management AB maintained a portfolio of 46 distinct positions. The most significant new addition to the portfolio was CVS HEALTH CORP, which now represents 2.70% of the total fund value. They heavily accumulated shares in AbbVie Inc, increasing their position by 17.5%. Conversely, Atle Fund Management AB completely exited their position in Edwards Lifesciences.
Total Positions
46
Quarter
2025 Q4
Top Holding
LLY (10.7%)
Top 10 Concentration
53.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 46
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co
|
Healthcare | 10.67% | 11.19% |
#1
Prev: #1
|
4.3 | -6,111 | -16.4% |
P
S
|
31,133 | $33,458,012 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABBV
AbbVie Inc
|
Healthcare | 7.89% | 8.40% |
#2
Prev: #2
|
5.2 | 16,076 | 17.5% |
P
S
|
108,181 | $24,718,276 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRK
Merck & Co. Inc
|
Healthcare | 6.57% | 5.32% |
#3
1
Prev: #4
|
4.7 | 34,855 | 21.7% |
P
S
|
195,768 | $20,606,539 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TMO
Thermo Fisher S...
|
Healthcare | 5.53% | 5.18% |
#4
1
Prev: #5
|
4.2 | 2,768 | 10.2% |
P
S
|
29,915 | $17,334,246 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NBIX
Neurocrine Bios...
|
Healthcare | 4.29% | 5.67% |
#5
2
Prev: #3
|
1.7 | -7,829 | -7.6% |
P
S
|
94,796 | $13,444,916 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ISRG
Intuitive Surgi...
|
Healthcare | 4.03% | 3.47% |
#6
3
Prev: #9
|
3.7 | 2,615 | 13.3% |
P
S
|
22,322 | $12,642,287 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ONC
BEONE MEDICINES...
|
Healthcare | 3.92% | 4.07% |
#7
1
Prev: #6
|
3.7 | 10,099 | 33.3% |
P
S
|
40,432 | $12,283,645 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBIO
Bridgebio Pharm...
|
Healthcare | 3.45% | 3.57% |
#8
1
Prev: #7
|
1.4 | -33,426 | -19.1% |
P
S
|
141,296 | $10,807,731 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRTX
Vertex Pharmace...
|
Healthcare | 3.32% | 2.74% |
#9
6
Prev: #15
|
3.4 | 5,218 | 29.4% |
P
S
|
22,984 | $10,420,026 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BSX
Boston Scientif...
|
Healthcare | 3.31% | 3.33% |
#10
1
Prev: #11
|
3.4 | 22,002 | 25.4% |
P
S
|
108,682 | $10,362,828 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SYK
Stryker Corpora...
|
Healthcare | 3.01% | 3.31% |
#11
1
Prev: #12
|
3.3 | 4,066 | 17.9% |
P
S
|
26,835 | $9,431,697 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CVS
CVS HEALTH CORP
|
Healthcare | 2.70% | — |
#12
Prev: #—
|
3.1 | 106,518 | no change |
NEW
|
106,518 | $8,453,268 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KRYS
Krystal Biotech...
|
Healthcare | 2.66% | 2.93% |
#13
1
Prev: #14
|
1.1 | -8,338 | -19.8% |
P
S
|
33,853 | $8,346,118 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COR
Cencora Inc
|
Healthcare | 2.56% | 3.52% |
#14
6
Prev: #8
|
1.1 | -4,835 | -16.9% |
P
S
|
23,773 | $8,029,330 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 2.33% | — |
#15
Prev: #—
|
2.9 | 92,377 | no change |
NEW
|
92,377 | $7,307,944 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
REVOLUTION Medi...
|
Healthcare | 2.29% | 1.57% |
#16
8
Prev: #24
|
2.9 | 4,829 | 5.7% |
P
S
|
90,184 | $7,183,155 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMGN
Amgen Inc
|
Healthcare | 2.29% | 1.53% |
#17
8
Prev: #25
|
3.1 | 8,097 | 58.6% |
P
S
|
21,903 | $7,169,070 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MIRM
Mirum Pharmaceu...
|
Healthcare | 2.26% | 2.70% |
#18
2
Prev: #16
|
0.9 | -3,920 | -4.2% |
P
S
|
89,685 | $7,084,218 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INCY
INCYTE CORP
|
Healthcare | 2.23% | — |
#19
Prev: #—
|
2.9 | 70,851 | no change |
NEW
|
70,851 | $6,997,953 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NAMS
NewAmsterdam Ph...
|
Healthcare | 2.21% | 2.17% |
#20
3
Prev: #17
|
2.9 | 3,411 | 1.8% |
P
S
|
197,036 | $6,912,022 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALKS
Alkermes PLC
|
Healthcare | 2.16% | 2.99% |
#21
8
Prev: #13
|
0.9 | -10,402 | -4.1% |
P
S
|
242,473 | $6,784,394 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRTC
iRhythm Technol...
|
Healthcare | 2.13% | 2.03% |
#22
4
Prev: #18
|
2.9 | 7,588 | 25.3% |
P
S
|
37,579 | $6,668,017 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GILD
Gilead Sciences...
|
Healthcare | 1.99% | 3.42% |
#23
13
Prev: #10
|
0.9 | -27,373 | -35.0% |
P
S
|
50,796 | $6,234,701 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UFPT
UFP Technologie...
|
Healthcare | 1.63% | 1.81% |
#24
3
Prev: #21
|
0.7 | no change | no change |
P
S
|
22,986 | $5,103,581 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSM
INSMED INC
|
Healthcare | 1.55% | — |
#25
Prev: #—
|
2.6 | 27,873 | no change |
NEW
|
27,873 | $4,851,016 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EW
Edwards Lifesci...
|
Healthcare | 0.00% | 2.01% |
Sold All 😨
(Was: #19) |
0.3 | -65,659 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRUS
Merus N.V.
|
Healthcare | 0.00% | 1.78% |
Sold All 😨
(Was: #22) |
0.3 | -47,999 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HRMY
Harmony Bioscie...
|
Healthcare | 0.00% | 1.00% |
Sold All 😨
(Was: #30) |
0.3 | -92,074 | -100.0% |
CLOSED
|
— | $— | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RNA
Avidity Bioscie...
|
Healthcare | 0.00% | 0.89% |
Sold All 😨
(Was: #31) |
0.3 | -51,978 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SMMT
Summit Therapeu...
|
Healthcare | 0.00% | 0.75% |
Sold All 😨
(Was: #34) |
0.3 | -92,737 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MREO
Mereo Biopharma...
|
Healthcare | 0.00% | 0.62% |
Sold All 😨
(Was: #37) |
0.3 | -764,901 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JANX
Janux Therapeut...
|
Healthcare | 0.00% | 0.48% |
Sold All 😨
(Was: #38) |
0.3 | -49,820 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 46 holdings